|
1
|
Sharma R, Abbasi-Kangevari M, Abd-Rabu R,
Abidi H, Abu-Gharbieh E, Acuna JM, Adhikari S, Advani SM, Afzal MS,
Aghaie Meybodi M, et al: Global, regional, and national burden of
colorectal cancer and its risk factors, 1990–2019: A systematic
analysis for the global burden of disease study 2019. Lancet
Gastroenterol Hepatol. 7:627–647. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Goïta AA and Guenot D: Colorectal cancer:
The contribution of CXCL12 and its receptors CXCR4 and CXCR7.
Cancers (Basel). 14:18102022. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kumar A, Gautam V, Sandhu A, Rawat K,
Sharma A and Saha L: Current and emerging therapeutic approaches
for colorectal cancer: A comprehensive review. World J Gastrointest
Surg. 15:495–519. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li Q, Geng S, Luo H, Wang W, Mo YQ, Luo Q,
Wang L, Song GB, Sheng JP and Xu B: Signaling pathways involved in
colorectal cancer: Pathogenesis and targeted therapy. Signal
Transduct Target Ther. 9:2662024. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jayanthi P, Varun BR and Selvaraj J:
Epithelial-mesenchymal transition in oral squamous cell carcinoma:
An insight into molecular mechanisms and clinical implications. J
Oral Maxillofac Pathol. 24:1892020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xue VW, Chung JYF, Córdoba CAG, Cheung AH,
Kang W, Lam EW, Leung KT, To KF, Lan HY and Tang PM: Transforming
growth factor-β: A multifunctional regulator of cancer immunity.
Cancers (Basel). 12:30992020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Baba AB, Rah B, Bhat GR, Mushtaq I,
Parveen S, Hassan R, Hameed Zargar M and Afroze D: Transforming
growth factor-beta (TGF-β) signaling in cancer-a betrayal within.
Front Pharmacol. 13:7912722022. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jaiganesh A, Narui Y, Araya-Secchi R and
Sotomayor M: Beyond cell-cell adhesion: Sensational cadherins for
hearing and balance. Cold Spring Harb Perspect Biol.
10:a0292802018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kaszak I, Witkowska-Piłaszewicz O,
Niewiadomska Z, Dworecka-Kaszak B, Ngosa Toka F and Jurka P: Role
of cadherins in cancer-a review. Int J Mol Sci. 21:76242020.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu QJ, Zhang TN, Chen HH, Yu XF, Lv JL,
Liu YY, Liu YS, Zheng G, Zhao JQ, Wei YF, et al: The sirtuin family
in health and disease. Signal Transduct Target Ther. 7:4022022.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhao L, Cao J, Hu K, He X, Yun D, Tong T
and Han L: Sirtuins and their biological relevance in aging and
age-related diseases. Aging Dis. 11:927–945. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lee GJ, Jung YH, Kim TJ, Chong Y, Jeong
SW, Lee IK and Woo IS: Surtuin 1 as a potential prognostic
biomarker in very elderly patients with colorectal cancer. Korean J
Intern Med. 36 (Suppl 1):S235–S244. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Khalil EH, Shaker OG and Hasona NA: Impact
of rs2107425 polymorphism and expression of lncH19 and miR-200a on
the susceptibility of colorectal cancer. Indian J Clin Biochem.
38:331–337. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Khalil EH, Shaker OG and Hasona NA: lncRNA
H-19 and miR-200a implication and frequency of lncRNA H-19
rs2170425 SNP in ulcerative colitis and Crohn's disease. Comp Clin
Pathol. 32:565–571. 2023. View Article : Google Scholar
|
|
15
|
Colangelo T, Fucci A, Votino C, Sabatino
L, Pancione M, Laudanna C, Binaschi M, Bigioni M, Maggi CA, Parente
D, et al: MicroRNA-130b promotes tumor development and is
associated with poor prognosis in colorectal cancer. Neoplasia.
15:1086–1099. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Khaliefa AK, Desouky EM, Hozayen WG,
Shaaban SM and Hasona NA: miRNA-1246, HOTAIR, and IL-39 signature
as potential diagnostic biomarkers in breast cancer. Noncoding RNA
Res. 8:205–210. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
DiStefano JK and Gerhard GS: Long
noncoding RNAs and human liver disease. Annu Rev Pathol. 17:1–21.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gao Y, Wang JW, Ren JY, Guo M, Guo CW,
Ning SW and Yu S: Long noncoding RNAs in gastric cancer: From
molecular dissection to clinical application. World J
Gastroenterol. 26:3401–3412. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen S, Zhang C and Feng M: Prognostic
Value of LncRNA HOTAIR in colorectal cancer: A meta-analysis. Open
Med (Wars). 15:76–83. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang J, Qiu WQ, Zhu H, Liu H, Sun JH,
Chen Y, Shen H, Qian CL and Shen ZY: HOTAIR contributes to the
carcinogenesis of gastric cancer via modulating cellular and
exosomal miRNAs level. Cell Death Dis. 11:7802020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jass JR, Sobin LH and Watanabe H: The
World Health Organization's histologic classification of
gastrointestinal tumors. A commentary on the second edition.
Cancer. 66:2162–2167. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ayeldeen G, Shaker OG, Khairy AM, Elfert
AY and Hasona NA: Signature of micro RNA 146a/215 and IL-6/TGF-β
levels in a cross-link axis between obesity and colorectal cancer.
Noncoding RNA Res. 8:187–191. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Abdel Hameed NA, Shaker OG and Hasona NA:
Significance of LINC00641 and miR-378 as a potential biomarker for
colorectal cancer. Comp Clin Pathol. 31:807–814. 2022. View Article : Google Scholar
|
|
25
|
Ratti M, Lampis A, Ghidini M, Salati M,
Mirchev MB, Valeri N and Hahne JC: MicroRNAs (miRNAs) and long
non-coding RNAs (lncRNAs) as new tools for cancer therapy: First
steps from bench to bedside. Target Oncol. 15:261–278. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang JY, Yang Y, Ma Y, Wang F, Xue A, Zhu
J, Yang H, Chen Q, Chen M, Ye L, et al: Potential regulatory role
of lncRNA-miRNA-mRNA axis in osteosarcoma. Biomed Pharmacother.
121:1096272020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Statello L, Guo CJ, Chen LL and Huarte M:
Gene regulation by long non-coding RNAs and its biological
functions. Nat Rev Mol Cell Biol. 22:96–118. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shengnan J, Dafei X, Hua J, Sunfu F,
Xiaowei W and Liang X: Long non-coding RNA HOTAIR as a competitive
endogenous RNA to sponge miR-206 to promote colorectal cancer
progression by activating CCL2. J Cancer. 11:4431–4441. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen W, Tong K and Yu J: MicroRNA-130a is
upregulated in colorectal cancer and promotes cell growth and
motility by directly targeting forkhead box F2. Mol Med Rep.
16:5241–5248. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu L, Nie J, Chen L, Dong G, Du X, Wu X,
Tang Y and Han W: The oncogenic role of microRNA-130a/301a/454 in
human colorectal cancer via targeting Smad4 expression. PLoS One.
8:e555322013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang M, Wu K, Zhang P, Qiu Y, Bai F and
Chen H: HOTAIR Facilitates endocrine resistance in breast cancer
through ESR1/miR-130b-3p axis: Comprehensive analysis of
mRNA-miRNA-lncRNA network. Int J Gen Med. 14:4653–4663. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li T, Liu N, Gao Y, Quan Z, Hao Y, Yu C,
Li L, Yuan M, Niu L, Luo C and Wu X: Long noncoding RNA HOTAIR
regulates the invasion and metastasis of prostate cancer by
targeting hepaCAM. Br J Cancer. 124:247–258. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ren MM, Xu S, Wei YB, Yang JJ, Yang YN,
Sun SS, Li YJ, Wang PY and Xie SY: Roles of HOTAIR in lung cancer
susceptibility and prognosis. Mol Genet Genomic Med. 8:e12992020.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang X, Huang L, Zhao Y and Tan W:
Downregulation of miR-130a contributes to cisplatin resistance in
ovarian cancer cells by targeting X-linked inhibitor of apoptosis
(XIAP) directly. Acta Biochim Biophys Sin (Shanghai). 45:995–1001.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang L, Ji F, Liu G, Wang W, Li Z, Yue Y
and Wang Z: Upregulation of circulating miR130a is correlated with
development of Barrett's esophagus and esophageal adenocarcinoma.
Onco Targets Ther. 12:1–7. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
El-Naidany SS, Zid E, Reda FM, Nada A and
Fouda EAM: Clinical significance of MiR-130b and MiR-125b as
biomarkers in hepatocellular carcinoma. Asian Pac J Cancer Prev.
23:2687–2693. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hu W, Zheng X, Liu J, Zhang M, Liang Y and
Song M: MicroRNA MiR-130a-3p promotes gastric cancer by targeting
Glucosaminyl N-acetyl transferase 4 (GCNT4) to regulate the
TGF-β1/SMAD3 pathway. Bioengineered. 12:11634–11647. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang J, Zhao L, Peng X, Liu K, Zhang C,
Chen X, Han Y and Lai Y: Evaluation of miR-130 family members as
circulating biomarkers for the diagnosis of bladder cancer. J Clin
Lab Anal. 34:e235172020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Waldner MJ and Neurath MF: TGFβ and the
tumor microenvironment in colorectal cancer. Cells. 12:11392023.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chan MKK, Chan ELY, Ji ZZ, Chan ASW, Li C,
Leung KT, To KF and Tang PMK: Transforming growth factor-β
signaling: From tumor microenvironment to anticancer therapy.
Explor Target Antitumor Ther. 4:316–343. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Khalil M, Desouky EM, Khaliefa AK, Hozyen
WG, Mohamed SS and Hasona NA: Insights into the crosstalk between
miR-200a/lncRNA H-19 and IL-6/SIRT-1 axis in breast cancer. J
Interferon Cytokine Res. 44:191–197. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yu DF, Jiang SJ, Pan ZP, Cheng WD, Zhang
WJ, Yao XK, Li YC and Lun YZ: Expression and clinical significance
of Sirt1 in colorectal cancer. Oncol Lett. 11:1167–1172. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Hydru SP and Das NM: Expression of
E-cadherin in colorectal cancer and its association with
morphological features. J Evolution Med Dent Sci. 11:163–168. 2022.
View Article : Google Scholar
|
|
44
|
Nagathihalli NS and Merchant NB:
Src-mediated regulation of E-cadherin and EMT in pancreatic cancer.
Front Biosci (Landmark Ed). 17:2059–2069. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Carafa V, Altucci L and Nebbioso A: Dual
tumor suppressor and tumor promoter action of sirtuins in
determining malignant phenotype. Front Pharmacol. 9:4166872019.
|
|
46
|
Palmirotta R, Cives M, Della-Morte D,
Capuani B, Lauro D, Guadagni F and Silvestris F: Sirtuins and
cancer: Role in the epithelial-mesenchymal transition. Oxid Med
Cell Longev. 2016:30314592016. View Article : Google Scholar : PubMed/NCBI
|
